Clinical Trials Browser

Completed × enzalutamide × 30 days × Clear all

NCT02225704 2026-04-13

Radium-223 in Combination With Enzalutamide

Phase 2 Completed

Prostatic Neoplasms

NCT03674814 2026-03-31

Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms